Our present results indicate that cardiac vascular endothelial Ets1 is down‐regulated during the course of diabetes progression, and overexpression of Ets1 in endothelial cells can alleviate diabetic vascular sparsity, fibrosis, inflammatory infiltration, and overall vascular dysfunction. This evidence concerns the gene ETS1 and diabetes mellitus.